• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/52

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

52 Cards in this Set

  • Front
  • Back
eclipse period
absense of detetable virion
cytophathic effect CPE
infecton becomes visible
plaques
colonies of dead cells on agar plate -> PFU
inclusion bodies
histological stain, reveal suspected identity
neutralization
complex w/ specific Ab, loose infectivity
seroconvertion
seronegative -> seropositive
window period
infection present but not detectable
nucleocapsid
protein coat, capsomers in helical/icosahedral
passive immunity
pass on immunity, poor sanitation -> everyone seropositive -> pass to newborns
host range
species that can be infected
tissue tropism
tissues that can be infected
incubation period
time between infection and onset of symptoms
interferon system
suppress viral growth, transient

virus infected cell -> alpha, beta
T cell -> gamma
virus inhibitory proteins
1. 2-5-A synthase
2. specific protein kinase
1. activate ribonuclease, destroy mRNA
2. phosphorylate/deactivate initiation factor
picornavirus
unenveloped single plus-strand RNA, icosahedral
poliomyelitis
picornavirus, enteric transmission, passive immunity, aseptic meningitis, infectious RNA, -> RNA dependant RNA polymerase
herd immunity
enough immune people -> no propagation
coxsackie virus
picornavirus
aseptic meningitis

group A: herpangia, hand-foot-and-mouth
group B: neonatal myocarditis, epidemic pleurodynia
ECHO virus
picornavirus
aseptic meningitis
rhinovirus
picornavirus
common colds, not enteric

not good at stomach pH, best at 33 degrees
hepatitis A
picornavirus
enteric, passive immunity, incubation: 30d, infect hepatocytes, elected LFT (aspartate aminotransferase), pooled IgG or killed.

IgG: previous
IgG + IgM: current
reovirus
unenveloped multiple double-strand RNA, icosahedral

viral RNA: mRNA template, contain RNA polymerase
rotavirus
reovirus, enteric

viral gastroenteritis
rx: rehydration
calcivirus
-hepatitis E
unenveloped plus-strand RNA, enteric
adenovirus
enveloped single double-strang DNA, assembled in nucleus

airborne -> common cold, kerato-conjunctivitis
enteric -> gastroenteritis, diarrhea
viral gastroenteritis
enteric, diarrhea/vomitting

rotavirus, adenovirus, norwalk virus
enveloped viruses
nucleocapsid coat, lipoprotein membrane
unstable, ether destroy infectivity, neutralization: Ab to glycoprotein
modified cellular membrane: budding, no damage
orthromyxovirus
enveloped multiple minus-strand RNA virus

strands in separate nucleocapsids, virus-specific RNA polymerase, envelope: lipids, glycoproteins
hemagglutinin (H-Ag)
H glycoprotein, adsorption of virion
neuraminidase (N-Ag)
N glycoprotein, enzyme: release new virion
hemagglutination
agglutinate red cells
influenza
orthromyxovirus

A, B, C: different nucleocapsids
influenza B
less severe, annual reformulation of killed vaccine
influenza A
minor/major epidemics
antigenic drift
minor epidemics

mutation in RNA segment or H-Ag
existing Ab -> partial immunity
antigenic shift
major pandemics

major variant in H-Ag or both
existing Ab -> no immunity
random reassortment
-> antigenic shift

virus affect same cell -> different genomes together
phenotypic mixing
virion assembled to diff virion components
influenza disease
subclinical infection, cough/sneeze transmission, infect upper respiratory

fever, chills, aches
complication: pneumonia
influenza immunology
infect mucosa -> IgA secretion
vaccine: polyvalent killed -> IgG response
treatment: amantadine/rimantadine -> prevent adsorption, oseltamivir/zanamivir: inhibit N -> slows release
paramyxovirus
enveloped single minus-strand RNA virus, contain polymerase

no recombination
mumps/measles
paramyxovirus, viremia -> systemic infection
parainfluenza
respiratory syncytial virus
paramyxovirus

non-systemic, sunblicnical, no antigenic shifts, hemagglutination
parainfluenza
paramyxovirus

acute laryngo-tracheo-bronchitis, dyspnea, stridor
rx: glucocorticoids
respiratory syncytial virus
paramyxovirus

lower respiratory infection
vaccine: monoclonal Ab
coronavirus
enveloped single plus-strand RNA virus

common cold
SARS
coronavirus

lower respirtory infection, dry cough, dyspnea, incubation: 2-10d
flavivirus

hepatitis C
enveloped plus-strang RNA virus

blood transmission, incubation: 60d, infect hepatocyptes
chronic -> cirrosis, hepatocellular carcinoma
rx: interferon-alpha
prodromal symptoms
nonspecific symptoms before definitive ones
hepadnavirus
enveloped circular double-strand DNA virus, isohedral

reverse transcriptase
hepatitis B
hepadnavirus

blood transmission, incubation: 70d, insidious onset
chronic -> hepatitis, liver carcinoma

serology: HBs -> HBc ->
HBeAg (core Ag): infectious, progression to carcinoma

vaccine: pooled human IgG, anti-HB Ig

rx: IFN-alpha
defective RNA virus

hepatitis D
circular minus-strand RNA virus

need coexistant HBV infection -> use envelope -> progeny